209 related articles for article (PubMed ID: 12956409)
1. Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels.
Wilson D; Massaeli H; Pierce GN; Zahradka P
Mol Cell Biochem; 2003 Jul; 249(1-2):141-9. PubMed ID: 12956409
[TBL] [Abstract][Full Text] [Related]
2. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
3. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.
Bellosta S; Baetta R; Canavesi M; Comparato C; Granata A; Monetti M; Cairoli F; Eberini I; Puglisi L; Corsini A
Pharmacol Res; 2007 Aug; 56(2):160-7. PubMed ID: 17582780
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells.
May AE; Schmidt R; Bülbül BO; Hölderle M; Walther F; Schömig A; Gawaz M; Klouche M
Thromb Haemost; 2005 Apr; 93(4):710-5. PubMed ID: 15841317
[TBL] [Abstract][Full Text] [Related]
5. Oxidized LDL inhibit hepatocyte growth factor synthesis in coronary smooth muscle cells.
Haug C; Lenz C; Bachem MG
Int J Cardiol; 2005 Sep; 103(3):298-306. PubMed ID: 16098393
[TBL] [Abstract][Full Text] [Related]
6. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells.
Haug C; Lenz C; Díaz F; Bachem MG
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1823-9. PubMed ID: 15319264
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
Torzewski M; Suriyaphol P; Paprotka K; Spath L; Ochsenhirt V; Schmitt A; Han SR; Husmann M; Gerl VB; Bhakdi S; Lackner KJ
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2130-6. PubMed ID: 15345515
[TBL] [Abstract][Full Text] [Related]
8. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells.
Huang Y; Mironova M; Lopes-Virella MF
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2640-7. PubMed ID: 10559006
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration.
Zhao B; Luo X; Shi H; Ma D
Thromb Res; 2011 Aug; 128(2):179-85. PubMed ID: 21458846
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro.
Yang SH; Li YT; Du DY
Thromb Res; 2013; 132(6):702-11. PubMed ID: 24144446
[TBL] [Abstract][Full Text] [Related]
11. Influence of oxidized low-density lipoprotein on vascular angiotensin II receptor expression.
Nickenig G; Sachinidis A; Seewald S; Böhm M; Vetter H
J Hypertens Suppl; 1997 Dec; 15(6):S27-30. PubMed ID: 9493124
[TBL] [Abstract][Full Text] [Related]
12. Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells.
Tsai KL; Chang YL; Huang PH; Cheng YH; Liu DH; Chen HY; Kao CL
J Vasc Surg; 2016 Jan; 63(1):204-15.e1. PubMed ID: 25080882
[TBL] [Abstract][Full Text] [Related]
13. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages.
Xu XP; Meisel SR; Ong JM; Kaul S; Cercek B; Rajavashisth TB; Sharifi B; Shah PK
Circulation; 1999 Mar; 99(8):993-8. PubMed ID: 10051290
[TBL] [Abstract][Full Text] [Related]
14. 17β-estradiol inhibits oxidized low-density lipoprotein-induced increase in matrix metalloproteinase-9 expression in human macrophages.
Uzui H; Sinha SK; Rajavashisth TB
J Investig Med; 2011 Oct; 59(7):1104-8. PubMed ID: 21760532
[TBL] [Abstract][Full Text] [Related]
15. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation.
Revuelta-López E; Castellano J; Roura S; Gálvez-Montón C; Nasarre L; Benitez S; Bayes-Genis A; Badimon L; Llorente-Cortés V
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2877-87. PubMed ID: 24072693
[TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes.
Ardans JA; Economou AP; Martinson JM; Zhou M; Wahl LM
J Leukoc Biol; 2002 Jun; 71(6):1012-8. PubMed ID: 12050187
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of matrix metalloproteinase-1 production and activation of platelet-derived growth factor receptor beta in human coronary smooth muscle cells by oxidized LDL and 4-hydroxynonenal.
Akiba S; Kumazawa S; Yamaguchi H; Hontani N; Matsumoto T; Ikeda T; Oka M; Sato T
Biochim Biophys Acta; 2006 Aug; 1763(8):797-804. PubMed ID: 16876267
[TBL] [Abstract][Full Text] [Related]
20. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix.
Marathe S; Kuriakose G; Williams KJ; Tabas I
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2648-58. PubMed ID: 10559007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
